<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32909054</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1084</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Mar</Month></PubDate></JournalIssue><Title>European radiology</Title><ISOAbbreviation>Eur Radiol</ISOAbbreviation></Journal><ArticleTitle>Amide signal intensities may be reduced in the motor cortex and the corticospinal tract of ALS patients.</ArticleTitle><Pagination><StartPage>1401</StartPage><EndPage>1409</EndPage><MedlinePgn>1401-1409</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00330-020-07243-4</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim of the study is to assess amide concentration changes in ALS patients compared with healthy controls by using quantitative amide proton transfer (APT) and multiparameter magnetic resonance imaging, and testing its correlation with clinical scores.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Sixteen ALS patients and sixteen healthy controls were recruited as part of the Canadian ALS Neuroimaging Consortium, and multimodal magnetic resonance imaging was performed at 3&#xa0;T, including APT and diffusion imaging. Lorentz fitting was used to quantify the amide effect. Clinical disability was evaluated using the revised ALS functional rating scale (ALSFRS-R), and its correlation with image characteristics was assessed. The diagnostic performance of different imaging parameters was evaluated with receiver operating characteristic analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our results showed that the amide peak was significantly different between the motor cortex and other gray matter territories within the brain of ALS patients (p&#x2009;&lt;&#x2009;0.001). Compared with controls, amide signal intensities in ALS were significantly reduced in the motor cortex (p&#x2009;&lt;&#x2009;0.001) and corticospinal tract (p&#x2009;=&#x2009;0.046), while abnormalities were not detected using routine imaging methods. There was no significant correlation between amide and ALSFRS-R score. The diagnostic accuracy of the amide peak was superior to that of diffusion imaging.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study demonstrated changes of amide signal intensities in the motor cortex and corticospinal tract of ALS patients.</AbstractText><AbstractText Label="KEY POINTS" NlmCategory="CONCLUSIONS">&#x2022; The neurodegenerative disease amyotrophic lateral sclerosis (ALS) has a lack of objective imaging indicators for diagnosis and assessment. &#x2022; Analysis of amide proton transfer imaging revealed changes in the motor cortex and corticospinal tract of ALS patients that were not visible on standard magnetic resonance imaging. &#x2022; The diagnostic accuracy of the amide peak was superior to that of diffusion imaging.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Zhuozhi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Radiology, 2nd Affiliated Hospital of Shantou University Medical College, Shantou, 515041, Guangdong, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Alberta, Edmonton, Alberta, T6G 2V2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalra</LastName><ForeName>Sanjay</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine (Neurology), University of Alberta, Edmonton, Alberta, T6G 2S2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mah</LastName><ForeName>Dennell</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine (Neurology), University of Alberta, Edmonton, Alberta, T6G 2S2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seres</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Alberta, Edmonton, Alberta, T6G 2V2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Hongfu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>School of Information Technology and Electrical Engineering, University of Queensland, Brisbane, Queensland, 4072, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Renhua</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Radiology, 2nd Affiliated Hospital of Shantou University Medical College, Shantou, 515041, Guangdong, China. rhwu@stu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilman</LastName><ForeName>Alan H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Alberta, Edmonton, Alberta, T6G 2V2, Canada. wilman@ualberta.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>81471730</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>31870981</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>2018A030307057</GrantID><Agency>Natural Science Foundation of Guangdong Province</Agency><Country/></Grant><Grant><GrantID>2020KZDZX1085</GrantID><Agency>Department of Education of Guangdong Province</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur Radiol</MedlineTA><NlmUniqueID>9114774</NlmUniqueID><ISSNLinking>0938-7994</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000577">Amides</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C565957">Amyotrophic Lateral Sclerosis 2, Juvenile</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000577" MajorTopicYN="N">Amides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="Y">Motor Cortex</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011712" MajorTopicYN="N">Pyramidal Tracts</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Brain</Keyword><Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>10</Day><Hour>5</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32909054</ArticleId><ArticleId IdType="doi">10.1007/s00330-020-07243-4</ArticleId><ArticleId IdType="pii">10.1007/s00330-020-07243-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kiernan MC, Vucic S, Cheah BC et al (2011) Amyotrophic lateral sclerosis. Lancet 377:942&#x2013;955</Citation><ArticleIdList><ArticleId IdType="pubmed">21296405</ArticleId><ArticleId IdType="pmc">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>McCampbell A, Cole T, Wegener AJ et al (2018) Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models. J Clin Investig 128:3558&#x2013;3567</Citation><ArticleIdList><ArticleId IdType="pubmed">30010620</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott A (2017) Drug therapy: on the treatment trail for ALS. Nature 550:S120&#x2013;s121</Citation><ArticleIdList><ArticleId IdType="pubmed">29045376</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A, Drory V, Hardiman O et al (2015) A revision of the El Escorial criteria-2015. Amyotroph Lateral Scler Frontotemporal Degener 16:291&#x2013;292</Citation><ArticleIdList><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrooten M, Smetcoren C, Robberecht W, Van Damme P (2011) Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: a prospective study. Ann Neurol 70:79&#x2013;83</Citation><ArticleIdList><ArticleId IdType="pubmed">21437935</ArticleId></ArticleIdList></Reference><Reference><Citation>Menke RA, Agosta F, Grosskreutz J, Filippi M, Turner MR (2017) Neuroimaging endpoints in amyotrophic lateral sclerosis. Neurotherapeutics 14:11&#x2013;23</Citation><ArticleIdList><ArticleId IdType="pubmed">27752938</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon NG, Turner MR, Vucic S et al (2014) Quantifying disease progression in amyotrophic lateral sclerosis. Ann Neurol 76:643&#x2013;657</Citation><ArticleIdList><ArticleId IdType="pubmed">25223628</ArticleId><ArticleId IdType="pmc">4305209</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty S, Gupta A, Nguyen T, Bourque P (2015) The &#x201c;motor band sign:&#x201d; susceptibility-weighted imaging in amyotrophic lateral sclerosis. Can J Neurol Sci 42:260&#x2013;263</Citation><ArticleIdList><ArticleId IdType="pubmed">25971894</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J, Ma L (2010) Study of the features of proton MR spectroscopy (1H-MRS) on amyotrophic lateral sclerosis. J Magn Reson Imaging 31:305&#x2013;308</Citation><ArticleIdList><ArticleId IdType="pubmed">20099342</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Ma L (2010) Grey matter volume changes over the whole brain in amyotrophic lateral sclerosis: a voxel-wise meta-analysis of voxel based morphometry studies. Amyotroph Lateral Scler 11:549&#x2013;554</Citation><ArticleIdList><ArticleId IdType="pubmed">20929296</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai Z, Chen Y, Yan G, Shen Z, Wu R (2019) Progress of magnetic resonance imaging in amyotrophic lateral sclerosis. Radiol Infect Dis 6:1&#x2013;7</Citation></Reference><Reference><Citation>Zhou J, Payen J-F, Wilson DA, Traystman RJ, van Zijl PC (2003) Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med 9:1085&#x2013;1090</Citation><ArticleIdList><ArticleId IdType="pubmed">12872167</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones KM, Pollard AC, Pagel MD (2018) Clinical applications of chemical exchange saturation transfer (CEST) MRI. J Magn Reson Imaging 47:11&#x2013;27</Citation><ArticleIdList><ArticleId IdType="pubmed">28792646</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Lal B, Wilson DA, Laterra J, van Zijl P (2003) Amide proton transfer (APT) contrast for imaging of brain tumors. Magn Reson Med 50:1120&#x2013;1126</Citation><ArticleIdList><ArticleId IdType="pubmed">14648559</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Tryggestad E, Wen Z et al (2011) Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med 17:130&#x2013;134</Citation></Reference><Reference><Citation>Lin G, Zhuang C, Shen Z et al (2018) APT weighted MRI as an effective imaging protocol to predict clinical outcome after acute ischemic stroke. Front Neurol 9:901</Citation><ArticleIdList><ArticleId IdType="pubmed">30405523</ArticleId><ArticleId IdType="pmc">6205981</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Wang W, Jiang S et al (2017) Amide proton transfer-weighted MRI detection of traumatic brain injury in rats. J Cereb Blood Flow Metab 37:3422&#x2013;3432</Citation><ArticleIdList><ArticleId IdType="pubmed">28128026</ArticleId><ArticleId IdType="pmc">5624391</ArticleId></ArticleIdList></Reference><Reference><Citation>Lokesh N, Seegerer A, Hioe J, Gschwind RM (2018) Chemical exchange saturation transfer in chemical reactions: a mechanistic tool for NMR detection and characterization of transient intermediates. J Am Chem Soc 140:1855&#x2013;1862</Citation><ArticleIdList><ArticleId IdType="pubmed">29336150</ArticleId><ArticleId IdType="pmc">6301330</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G, Liang Y, Bar-Shir A et al (2011) Monitoring enzyme activity using a diamagnetic chemical exchange saturation transfer MRI contrast agent. J Am Chem Soc 133(41):16326&#x2013;16329</Citation></Reference><Reference><Citation>Zhuang Z, Shen Z, Chen Y et al (2018) Mapping the changes of glutamate using glutamate chemical exchange saturation transfer (GluCEST) technique in a traumatic brain injury model: a longitudinal pilot study. ACS Chem Nerosci 10(1):649&#x2013;657</Citation></Reference><Reference><Citation>van Zijl PCM, Yadav NN (2011) Chemical exchange saturation transfer (CEST): what is in a name and what isn&#x2019;t? Magn Reson Med 65:927&#x2013;948</Citation><ArticleIdList><ArticleId IdType="pubmed">21337419</ArticleId><ArticleId IdType="pmc">3148076</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun PZ, Xiao G, Zhou IY, Guo Y, Wu R (2016) A method for accurate pH mapping with chemical exchange saturation transfer (CEST) MRI. Contrast Media Mol Imaging 11:195&#x2013;202</Citation><ArticleIdList><ArticleId IdType="pubmed">26689424</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu R, Xiao G, Zhou IY, Ran C, Sun PZ (2015) Quantitative chemical exchange saturation transfer (qCEST) MRI - omega plot analysis of RF-spillover-corrected inverse CEST ratio asymmetry for simultaneous determination of labile proton ratio and exchange rate. NMR Biomed 28:376&#x2013;383</Citation><ArticleIdList><ArticleId IdType="pubmed">25615718</ArticleId><ArticleId IdType="pmc">4339459</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai Z, Ji J, Xiao G et al (2014) Magnetization transfer prepared gradient echo MRI for CEST imaging. PLoS One 9:e112219</Citation><ArticleIdList><ArticleId IdType="pubmed">25384020</ArticleId><ArticleId IdType="pmc">4226502</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Pradat P-F, Ludolph AC, Loeffler J-P (2011) Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol 10:75&#x2013;82</Citation><ArticleIdList><ArticleId IdType="pubmed">21035400</ArticleId></ArticleIdList></Reference><Reference><Citation>Pyra T, Hui B, Hanstock C et al (2010) Combined structural and neurochemical evaluation of the corticospinal tract in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 11:157&#x2013;165</Citation><ArticleIdList><ArticleId IdType="pubmed">19242831</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong JC, Concha L, Beaulieu C, Johnston W, Allen PS, Kalra S (2007) Spatial profiling of the corticospinal tract in amyotrophic lateral sclerosis using diffusion tensor imaging. J Neuroimaging 17:234&#x2013;240</Citation><ArticleIdList><ArticleId IdType="pubmed">17608909</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu R, Bruening R (2006) Comparison of diffusion-weighted MR imaging and T2-weighted MR imaging in patients with amyotrophic lateral sclerosis. Neuroradiol J 19:705&#x2013;710</Citation></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 169:13&#x2013;21</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M, Gillen J, Landman BA, Zhou J, van Zijl PCM (2009) Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments. Magn Reson Med 61:1441&#x2013;1450</Citation><ArticleIdList><ArticleId IdType="pubmed">19358232</ArticleId><ArticleId IdType="pmc">2860191</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Heo HY, Knutsson L, van Zijl PCM, Jiang S (2019) APT-weighted MRI: techniques, current neuro applications, and challenging issues. J Magn Reson Imaging 50:347&#x2013;364</Citation><ArticleIdList><ArticleId IdType="pubmed">30663162</ArticleId><ArticleId IdType="pmc">6625919</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E, Wu Y, Cheung JS et al (2019) Mapping tissue pH in an experimental model of acute stroke - determination of graded regional tissue pH changes with non-invasive quantitative amide proton transfer MRI. Neuroimage 191:610&#x2013;617</Citation></Reference><Reference><Citation>By S, Barry RL, Smith AK et al (2018) Amide proton transfer CEST of the cervical spinal cord in multiple sclerosis patients at 3T. Magn Reson Med 79:806&#x2013;814</Citation><ArticleIdList><ArticleId IdType="pubmed">28474409</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, Shang Y, Redmond SA et al (2016) Activation of HIPK2 promotes ER stress-mediated neurodegeneration in amyotrophic lateral sclerosis. Neuron 91:41&#x2013;55</Citation><ArticleIdList><ArticleId IdType="pubmed">27321923</ArticleId><ArticleId IdType="pmc">4938715</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes J (1982) Pathology of amyotrophic lateral sclerosis. Adv Neurol 36:61&#x2013;74</Citation><ArticleIdList><ArticleId IdType="pubmed">7180695</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodge JC, Treleaven CM, Fidler JA et al (2013) Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis. Proc Natl Acad Sci U S A 110:10812&#x2013;10817</Citation><ArticleIdList><ArticleId IdType="pubmed">23754387</ArticleId><ArticleId IdType="pmc">3696768</ArticleId></ArticleIdList></Reference><Reference><Citation>Szelechowski M, Amoedo N, Obre E et al (2018) Metabolic reprogramming in amyotrophic lateral sclerosis. Sci Rep 8:3953</Citation><ArticleIdList><ArticleId IdType="pubmed">29500423</ArticleId><ArticleId IdType="pmc">5834494</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RM, Irish M, Piguet O et al (2016) Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism. Lancet Neurol 15:332&#x2013;342</Citation><ArticleIdList><ArticleId IdType="pubmed">26822748</ArticleId></ArticleIdList></Reference><Reference><Citation>Kori M, Ayd&#x131;n B, Unal S, Arga KY, Kazan D (2016) Metabolic biomarkers and neurodegeneration: a pathway enrichment analysis of Alzheimer&#x2019;s disease, Parkinson&#x2019;s disease, and amyotrophic lateral sclerosis. OMICS 20:645&#x2013;661</Citation><ArticleIdList><ArticleId IdType="pubmed">27828769</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Chen G, He M et al (2018) Altered white matter microarchitecture in amyotrophic lateral sclerosis: a voxel-based meta-analysis of diffusion tensor imaging. Neuroimage Clin 19:122&#x2013;129</Citation><ArticleIdList><ArticleId IdType="pubmed">30035009</ArticleId><ArticleId IdType="pmc">6051469</ArticleId></ArticleIdList></Reference><Reference><Citation>List J, Kohl Z, Winkler J, Marxreiter F, Doerfler A, Schmidt MA (2019) Ascending axonal degeneration of the corticospinal tract in pure hereditary spastic paraplegia: a cross-sectional DTI study. Brain Sci 9</Citation></Reference><Reference><Citation>Li C, Peng S, Wang R et al (2014) Chemical exchange saturation transfer MR imaging of Parkinson&#x2019;s disease at 3 tesla. Eur Radiol 24:2631&#x2013;2639</Citation><ArticleIdList><ArticleId IdType="pubmed">25038850</ArticleId><ArticleId IdType="pmc">4471479</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Wang R, Chen H et al (2015) Chemical exchange saturation transfer MR imaging is superior to diffusion-tensor imaging in the diagnosis and severity evaluation of Parkinson&#x2019;s disease: a study on substantia nigra and striatum. Front Aging Neurosci 7:198</Citation><ArticleIdList><ArticleId IdType="pubmed">26539109</ArticleId><ArticleId IdType="pmc">4609848</ArticleId></ArticleIdList></Reference><Reference><Citation>Togao O, Yoshiura T, Keupp J et al (2013) Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades. Neuro Oncol 16:441&#x2013;448</Citation><ArticleIdList><ArticleId IdType="pubmed">24305718</ArticleId><ArticleId IdType="pmc">3922507</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldenberg JM, Pagel MD (2019) Assessments of tumor metabolism with CEST MRI. NMR Biomed 32:e3943</Citation><ArticleIdList><ArticleId IdType="pubmed">29938857</ArticleId></ArticleIdList></Reference><Reference><Citation>Roccatagliata L, Bonzano L, Mancardi G, Canepa C, Caponnetto C (2009) Detection of motor cortex thinning and corticospinal tract involvement by quantitative MRI in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10:47&#x2013;52</Citation><ArticleIdList><ArticleId IdType="pubmed">18622772</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Poptani H, Woo JH et al (2006) Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T. Radiology 239:831&#x2013;838</Citation><ArticleIdList><ArticleId IdType="pubmed">16641339</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindeman LR, Randtke EA, High RA, Jones KM, Howison CM, Pagel MD (2018) A comparison of exogenous and endogenous CEST MRI methods for evaluating in vivo pH. Magn Reson Med 79:2766&#x2013;2772</Citation><ArticleIdList><ArticleId IdType="pubmed">29024066</ArticleId></ArticleIdList></Reference><Reference><Citation>Albatany M, Li A, Meakin S, Bartha R (2018) Dichloroacetate induced intracellular acidification in glioblastoma: in vivo detection using AACID-CEST MRI at 9.4 tesla. J Neurooncol 136:255&#x2013;262</Citation><ArticleIdList><ArticleId IdType="pubmed">29143921</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri A, Coccurello R (2017) What is &#x201c;hyper&#x201d; in the ALS hypermetabolism? Mediators Inflamm 2017:7821672</Citation><ArticleIdList><ArticleId IdType="pubmed">29081604</ArticleId><ArticleId IdType="pmc">5610793</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera TW, Tan KN, McDonald TS, Borges K (2017) Alternative fuels in epilepsy and amyotrophic lateral sclerosis. Neurochem Res 42:1610&#x2013;1620</Citation><ArticleIdList><ArticleId IdType="pubmed">27868154</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermosura MC, Garruto RM (2007) TRPM7 and TRPM2-candidate susceptibility genes for Western Pacific ALS and PD? Biochim Biophys Acta 1772:822&#x2013;835</Citation><ArticleIdList><ArticleId IdType="pubmed">17395433</ArticleId><ArticleId IdType="pmc">1994999</ArticleId></ArticleIdList></Reference><Reference><Citation>Pal B (2018) Involvement of extrasynaptic glutamate in physiological and pathophysiological changes of neuronal excitability. Cell Mol Life Sci 75:2917&#x2013;2949</Citation><ArticleIdList><ArticleId IdType="pubmed">29766217</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, Mavel S, Corcia P, Gordon PH (2014) The glutamate hypothesis in ALS: pathophysiology and drug development. Curr Med Chem 21:3551&#x2013;3575</Citation><ArticleIdList><ArticleId IdType="pubmed">25245510</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawton KA, Cudkowicz ME, Brown MV et al (2012) Biochemical alterations associated with ALS. Amyotroph Lateral Scler 13:110&#x2013;118</Citation><ArticleIdList><ArticleId IdType="pubmed">22117131</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikawa M, Okazawa H, Tsujikawa T et al (2015) Increased oxidative stress is related to disease severity in the ALS motor cortex: a PET study. Neurology 84:2033&#x2013;2039</Citation><ArticleIdList><ArticleId IdType="pubmed">25904686</ArticleId></ArticleIdList></Reference><Reference><Citation>Behan AT, Breen B, Hogg M et al (2013) Acidotoxicity and acid-sensing ion channels contribute to motoneuron degeneration. Cell Death Differ 20:589&#x2013;598</Citation><ArticleIdList><ArticleId IdType="pubmed">23306556</ArticleId><ArticleId IdType="pmc">3595486</ArticleId></ArticleIdList></Reference><Reference><Citation>Friese MA, Craner MJ, Etzensperger R et al (2007) Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system. Nat Med 13:1483&#x2013;1489</Citation><ArticleIdList><ArticleId IdType="pubmed">17994101</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuzziello N, Liguori M (2019) The microRNA centrism in the orchestration of neuroinflammation in neurodegenerative diseases. Cells 8</Citation></Reference><Reference><Citation>Sun PZ, Wang Y, Dai ZZ, Xiao G, Wu RH (2014) Quantitative chemical exchange saturation transfer (qCEST) MRI - RF spillover effect-corrected omega plot for simultaneous determination of labile proton fraction ratio and exchange rate. Contrast Media Mol Imaging 9:268&#x2013;275</Citation><ArticleIdList><ArticleId IdType="pubmed">24706610</ArticleId><ArticleId IdType="pmc">4003506</ArticleId></ArticleIdList></Reference><Reference><Citation>Chitnis T, Weiner HL (2017) CNS inflammation and neurodegeneration. J Clin Invest 127:3577&#x2013;3587</Citation><ArticleIdList><ArticleId IdType="pubmed">28872464</ArticleId><ArticleId IdType="pmc">5617655</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito Y, Ofengeim D, Najafov A et al (2016) RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. Science 353:603&#x2013;608</Citation><ArticleIdList><ArticleId IdType="pubmed">27493188</ArticleId><ArticleId IdType="pmc">5444917</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaiss M, Kunz P, Goerke S, Radbruch A, Bachert P (2013) MR imaging of protein folding in vitro employing nuclear-Overhauser-mediated saturation transfer. NMR Biomed 26:1815&#x2013;1822</Citation><ArticleIdList><ArticleId IdType="pubmed">24115020</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenabi M, Peck KK, Young RJ, Brennan N, Holodny AI (2015) Identification of the corticobulbar tracts of the tongue and face using deterministic and probabilistic DTI fiber tracking in patients with brain tumor. AJNR Am J Neuroradiol 36:2036&#x2013;2041</Citation><ArticleIdList><ArticleId IdType="pubmed">26251424</ArticleId><ArticleId IdType="pmc">4982871</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo YL, Li SJ, Zhang ZP et al (2016) Parameters of diffusional kurtosis imaging for the diagnosis of acute cerebral infarction in different brain regions. Exp Ther Med 12:933&#x2013;938</Citation><ArticleIdList><ArticleId IdType="pubmed">27446298</ArticleId><ArticleId IdType="pmc">4950828</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Kang H, Zhao X et al (2016) Amide proton transfer (APT) MR imaging and magnetization transfer (MT) MR imaging of pediatric brain development. Eur Radiol 26:3368&#x2013;3376</Citation><ArticleIdList><ArticleId IdType="pubmed">26762941</ArticleId><ArticleId IdType="pmc">5747245</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellani M, Boschello F, Delvecchio G et al (2016) DTI and myelin plasticity in bipolar disorder: integrating neuroimaging and neuropathological findings. Front Psychiatry 7:21</Citation><ArticleIdList><ArticleId IdType="pubmed">26973545</ArticleId><ArticleId IdType="pmc">4771723</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Zhou IY, Lu D et al (2018) pH-sensitive amide proton transfer effect dominates the magnetization transfer asymmetry contrast during acute ischemia-quantification of multipool contribution to in vivo CEST MRI. Magn Reson Med 79:1602&#x2013;1608</Citation><ArticleIdList><ArticleId IdType="pubmed">28733991</ArticleId></ArticleIdList></Reference><Reference><Citation>Khlebnikov V, Siero JCW, Bhogal AA, Luijten PR, Klomp DWJ, Hoogduin H (2018) Establishing upper limits on neuronal activity-evoked pH changes with APT-CEST MRI at 7 T. Magn Reson Med 80:126&#x2013;136</Citation><ArticleIdList><ArticleId IdType="pubmed">29154463</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, Yadav NN, Zeng H et al (2016) Magnetization transfer contrast-suppressed imaging of amide proton transfer and relayed nuclear overhauser enhancement chemical exchange saturation transfer effects in the human brain at 7T. Magn Reson Med 75:88&#x2013;96</Citation><ArticleIdList><ArticleId IdType="pubmed">26445350</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstraete E, Polders DL, Mandl RC et al (2014) Multimodal tract-based analysis in ALS patients at 7T: a specific white matter profile? Amyotroph Lateral Scler Frontotemporal Degener 15:84&#x2013;92</Citation><ArticleIdList><ArticleId IdType="pubmed">24325276</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu B, Warnock G, Zaiss M et al (2016) An overview of CEST MRI for non-MR physicists. EJNMMI Phys 3:19</Citation><ArticleIdList><ArticleId IdType="pubmed">27562024</ArticleId><ArticleId IdType="pmc">4999387</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai K, Singh A, Poptani H et al (2015) CEST signal at 2 ppm (CEST@ 2ppm) from Z-spectral fitting correlates with creatine distribution in brain tumor. NMR Biomed 28:1&#x2013;8</Citation><ArticleIdList><ArticleId IdType="pubmed">25295758</ArticleId></ArticleIdList></Reference><Reference><Citation>Fieremans E, Jensen JH, Helpern JA (2011) White matter characterization with diffusional kurtosis imaging. Neuroimage 58:177&#x2013;188</Citation><ArticleIdList><ArticleId IdType="pubmed">21699989</ArticleId><ArticleId IdType="pmc">3136876</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>